Where can I find semaglutide weight loss near me in Northern Virginia?

Noor Esthetique & Wellness Center at 21430 Cedar Dr, Suite 214, #101, Sterling, VA 20164 offers physician-supervised semaglutide GLP-1 weight loss for patients throughout Loudoun County and Northern Virginia. Call (703) 996-4377.

What are the clinical trial results for semaglutide?

STEP 1 trial: ~15% total body weight loss over 68 weeks; ~70% of participants lost 10%+ body weight. SELECT trial (2023): 20% reduction in major cardiovascular events.

Physician-Led · Sterling, Virginia

Semaglutide Near You — Physician-Supervised GLP-1 Weight Loss Program at Noor Wellness

Noor Esthetique & Wellness Center in Sterling, VA offers physician-supervised semaglutide weight loss for patients throughout Northern Virginia and Loudoun County. Our GLP-1 program is built on a foundational difference from subscription-based telehealth services: a board-certified physician who evaluates you, designs your protocol, monitors your labs, and adjusts your dose based on your individual clinical response. Semaglutide — the active ingredient in Ozempic and Wegovy — has been validated in the largest obesity clinical trials ever conducted. At Noor, that evidence base is applied with the clinical precision your health deserves.

Or call 703-996-4377

What Semaglutide Is — And How It Works

Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist — a class of medication that mimics the action of a naturally occurring gut hormone that regulates appetite and blood sugar. By binding to GLP-1 receptors in the hypothalamus, GI tract, and pancreas, semaglutide produces:

Appetite suppression: Direct hypothalamic signaling reduces the neurological drive to eat
Delayed gastric emptying: Food stays in the stomach longer, extending the feeling of fullness
Improved insulin secretion: Glucose-dependent, meaning hypoglycemia risk is minimal in non-diabetic patients
Reduced food reward signaling: Emerging research shows GLP-1 activity in reward pathways reduces emotional and habitual drivers of overeating

Clinical Trial Results — What the Evidence Shows

Semaglutide's weight loss efficacy has been validated in the largest obesity clinical trials ever conducted.

STEP 1 Trial — gold standard for semaglutide 2.4mg weekly in adults with obesity

Mean total body weight loss: ~15% over 68 weeks
70.9% of participants achieved ≥10% weight loss
~30% achieved ≥20% weight loss

SELECT Trial (2023) — landmark cardiovascular outcomes study

These are not anecdotal results. They are the clinical foundation of semaglutide's role as the leading medical weight loss therapy available today.

20% reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death)
In overweight/obese adults with pre-existing cardiovascular disease
The first weight loss medication with a demonstrated cardiovascular benefit in a large RCT

Noor's Complete Semaglutide Program

Eligibility Consultation: Review of your weight history, current BMI, metabolic health markers, medications, and health goals with our board-certified physician.
Pre-Treatment Labs: Metabolic panel, HbA1c, lipid panel, thyroid function, liver function. Your physician reviews results and designs your individualized protocol.
Physician-Designed Titration: Starting at 0.25mg weekly, escalating on a schedule calibrated to your tolerability. Maximum therapeutic dose is 2.4mg weekly (Wegovy dosing). Compounded semaglutide is available for eligible patients.
Monthly Medical Monitoring: Weight tracking, side effect management, lab review, dose escalation. Your physician adjusts your protocol based on clinical response — not a preset calendar.
Men's Weight Loss: Men with confirmed low testosterone receive testosterone optimization concurrent with their GLP-1 program, addressing both hormonal and pharmacological drivers of weight gain simultaneously.
Long-Term Maintenance: Before you reach your goal weight, Noor develops your maintenance strategy — because weight regain after GLP-1 discontinuation is predictable and preventable with physician planning.

Who Should Consider Semaglutide?

Clinically appropriate for adults with:

BMI 30 or higher
BMI 27 or higher with at least one weight-related health condition (hypertension, type 2 diabetes, sleep apnea, cardiovascular disease, hyperlipidemia)

Contraindications

Semaglutide is contraindicated in patients with:

Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2)
Active or prior pancreatitis
Pregnancy

Why Choose Noor

Medical authority you can trust.

Physician-Led Care

Every protocol is designed and supervised by board-certified medical leadership — not by aestheticians or unlicensed staff.

Board-Certified Expertise

Our medical director brings a USAF Reserves medical background and years of internal medicine experience to every consultation.

Evidence-Based Protocols

Treatments are guided by current peer-reviewed research and adjusted to your individual labs, symptoms, and goals.

Frequently Asked

Questions patients ask before booking.

What makes Noor's semaglutide program different from telehealth services?

Noor's program is physician-led, lab-monitored, and clinical rather than subscription-based. Your physician reviews your labs, designs your titration, and adjusts your dose based on your response. This reduces side effects, improves adherence, and produces better outcomes than automated subscription services.

How long until I reach my goal weight?

Most patients achieve significant weight loss within 3-6 months and continue toward maximum efficacy at 12-18 months. Your physician at Noor establishes a realistic timeline based on your starting weight, metabolic health, and target.

Is the GLP-1 program available for men?

Yes. GLP-1 therapy is highly effective in men. For men with concurrent low testosterone, Noor offers integrated GLP-1 + TRT programs that address both drivers of male weight gain simultaneously.

What happens when I reach my goal weight?

Your physician designs a maintenance phase — continuing GLP-1 at a maintenance dose or transitioning to an alternative strategy. Weight regain after abrupt discontinuation is clinically predictable; maintenance planning prevents it.

Related Services

Continue exploring physician-led care.

Free Download

The GLP-1 Readiness Guide

Nine questions to answer before your first dose.

What no one tells you about month three. A physician's guide to semaglutide, tirzepatide, and compounded GLP-1s — before you start.

Ready to talk with a physician?

Schedule a consultation at Noor Esthétique & Wellness Center in Sterling, VA. No obligation — just an honest clinical conversation.

703-996-4377

Noor Esthétique & Wellness Center

Physician-led wellness & regenerative medicine

21430 Cedar Dr, Suite 214, #101

Sterling, VA 20164